HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Costeff syndrome: clinical features and natural history.

Abstract
Costeff syndrome (CS) is a rare autosomal-recessive neurological disorder, which is known almost exclusively in patients of Iraqi Jewish descent, manifesting in childhood with optic atrophy, ataxia, chorea and spastic paraparesis. Our aim was to study the clinical spectrum of CS and natural history using a cross-sectional study design. Consecutive patients with CS were recruited to the study. Patients were diagnosed based on clinical features, along with elevated urinary levels of methylglutaconic and methylglutaric acid, and by identification of the disease-causing mutation in the OPA3 gene in most. All patients were examined by a neurologist and signs and symptoms were rated. 28 patients with CS (16 males, 21 families, age at last observation 28.6 ± 16.1 years, range 0.5-68 years) were included. First signs of neurological deficit appeared in infancy or early childhood, with delayed motor milestones, choreiform movements, ataxia and visual disturbances. Ataxia and chorea were the dominant motor features in childhood, but varied in severity among patients and did not seem to worsen with age. Pyramidal dysfunction appeared later and progressed with age (r = 0.71, p < 0.001) leading to spastic paraparesis and marked gait impairment. The course of neurological deterioration was slow and the majority of patients could still walk beyond the fifth decade. While visual acuity seemed to deteriorate, it did not correlate with age. CS is a rare neurogenetic disorder that causes serious disability and worsens with age. Spasticity significantly increases over the years and is the most crucial determinant of neurological dysfunction.
AuthorsGilad Yahalom, Yair Anikster, Ruth Huna-Baron, Chen Hoffmann, Lubov Blumkin, Dorit Lev, Rakefet Tsabari, Zeev Nitsan, Sheera F Lerman, Bruria Ben-Zeev, Ben Pode-Shakked, Shira Sofer, Avraham Schweiger, Tally Lerman-Sagie, Sharon Hassin-Baer
JournalJournal of neurology (J Neurol) Vol. 261 Issue 12 Pg. 2275-82 (Dec 2014) ISSN: 1432-1459 [Electronic] Germany
PMID25201222 (Publication Type: Journal Article)
Chemical References
  • OPA3 protein, human
  • Proteins
Topics
  • Adolescent
  • Adult
  • Aged
  • Aging (pathology)
  • Child
  • Child, Preschool
  • Chorea (diagnosis, genetics, physiopathology, urine)
  • Cross-Sectional Studies
  • Female
  • Humans
  • Infant
  • Male
  • Metabolism, Inborn Errors (diagnosis, genetics, physiopathology, urine)
  • Middle Aged
  • Muscle Spasticity (physiopathology)
  • Optic Atrophy (diagnosis, genetics, physiopathology, urine)
  • Proteins (genetics)
  • Spastic Paraplegia, Hereditary (diagnosis, genetics, physiopathology, urine)
  • Young Adult

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: